Decreased immunoexpression of standard form of CD44 is an independent favourable predictor of nodal metastasis in colorectal carcinoma

Anticancer Research

Volumn 32, Issue 8, 2012, Pages 3455-3461

  Al Maghrabi, Jaudah ^a   Gomaa, Wafaey ^a,b   Buhmeida, Abdelbaset ^a   Al Qahtani, Mohmmad ^a   Al Ahwal, Mahmoud ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b Minia University   (Egypt)

Author keywords

CD44s; CRC; IHC; Lymph node status

Indexed keywords

HERMES ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; COLORECTAL CARCINOMA; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ANTIGENS, CD44; CARCINOMA; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED;

EID: 84865682877     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Huh JW, Kim HR, Kim YJ, Lee JH, Park YS, Cho SH and Joo JK: Expression of standard CD44 in human colorectal carcinoma: association with prognosis. Pathol Int 59(4): 241-246, 2009.
2. Kunimura T, Yoshida T, Sugiyama T and Morohoshi T: The Relationships Between Loss of Standard CD44 Expression and Lymph Node, Liver Metastasis in T3 Colorectal Carcinoma. J Gastrointest Cancer 40(3-4): 115-118, 2009.
3. Al-Eid H, Arteh S: Cancer Incidence Report Saudi Arabia. pp. 1-99, 2005.
4. Marhaba R and Zoller M: CD44 in cancer progression: adhesion, migration and growth regulation. J Molecul Histol 35(3): 211-231, 2004.
5. Goodfellow PN, Banting G, Wiles MV, Tunnacliffe A, Parkar M, Solomon E, Dalchau R and Fabre JW: The gene, MIC4, which controls expression of the antigen defined by monoclonal antibody F10.44.2, is on human chromosome 11. Euro J of Immunol 12(8): 659-663, 1982.
6. Terpe HJ, Stark H, Prehm P and Gunthert U: CD44 variant isoforms are preferentially expressed in basal epithelial of nonmalignant human fetal and adult tissues. Histochemistry 101(2): 79-89, 1994.
7. Goodison S, Urquidi V and Tarin D: CD44 cell adhesion molecules. Mol Pathol 52(4): 189-196, 1999.
8. Cooper DL, Dougherty G, Harn HJ, Jackson S, Baptist EW, Byers J, Datta A, Phillips G and Isola NR: The complex CD44 transcriptional unit; alternative splicing of three internal exons generates the epithelial form of CD44. Biochemical and biophysical research communications 182(2): 569-578, 1992.
9. Rudzki Z and Jothy S: CD44 and the adhesion of neoplastic cells. Mol Pathol 50(2): 57-71, 1997.
10. Jacobs PP and Sackstein R: CD44 and HCELL: preventing hematogenous metastasis at step 1. FEBS letters 585(20): 3148-3158, 2011.
11. Naor D, Nedvetzki S, Golan I, Melnik L and Faitelson Y: CD44 in cancer. Critical reviews in clinical laboratory sciences 39(6): 527-579, 2002.
12. Zavrides HN, Zizi-Sermpetzoglou A, Panousopoulos D, Athanasas G, Elemenoglou I and Peros G: Prognostic evaluation of CD44 expression in correlation with bcl-2 and p53 in colorectal cancer. Folia histochemica et cytobiologica/Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 43(1): 31-36, 2005.
13. Motoshita J, Nakayama H, Taniyama K, Matsusaki K and Yasui W: Molecular characteristics of differentiated-type gastric carcinoma with distinct mucin phenotype: LI-cadherin is associated with intestinal phenotype. Pathol Int 56(4): 200-205, 2006.
14. Sneath RJ and Mangham DC: The normal structure and function of CD44 and its role in neoplasia. Mol Pathol 51(4): 191-200, 1998.
15. Stamenkovic I, Amiot M, Pesando JM and Seed B: A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 56(6): 1057-1062, 1989.
16. Kim H, Yang XL, Rosada C, Hamilton SR and August JT: CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation. Archives of biochemistry and biophysics 310(2): 504-507, 1994.
17. Asao T, Nakamura J, Shitara Y, Tsutsumi S, Mochiki E, Shimura T, Takenoshita S and Kuwano H: Loss of standard type of CD44 expression in invaded area as a good indicator of lymph-node metastasis in colorectal carcinoma. Dis Colon Rectum 43(9): 1250-1254; discussion 1254-1255, 2000.
18. Wielenga VJ, van der Neut R, Offerhaus GJ and Pals ST: CD44 glycoproteins in colorectal cancer: expression, function, and prognostic value. Advances in Cancer Research 77: 169-187, 2000.
19. Ishida T: Immunohistochemical expression of the CD44 variant 6 in colorectal adenocarcinoma. Surg Today 30(1): 28-32, 2000.
20. Sokmen S, Lebe B, Sarioglu S, Fuzun M, Terzi C, Kupelioglu A and Ellidokuz H: Prognostic value of CD44 expression in colorectal carcinomas. Anticancer Res 21(6A): 4121-4126, 2001.
21. Liu YJ, Yan PS, Li J and Jia JF: Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer. World J Gastroenterol 11(42): 6601-6606, 2005.
22. Zalewski B, Famulski W, Sulkowska M, Sobaniec-Lotowska M, Piotrowski Z, Kisielewski W and Sulkowski S: CD44 expression in colorectal cancer. An immunohistochemical study including correlation with cathepsin D immunoreactivity and some tumour clinicopathological features. Folia histochemica et cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 39(Suppl 2): 152-153, 2001.
23. Zalewski B, Stasiak-Barmuta A, Sulkowski S, Piotrowski Z, Mysliwiec P and Kuklinski A: Glycoprotein CD44 variant 4 expression in tumour epithelial cells of patients with colorectal cancer. Roczniki Akademii Medycznej w Bialymstoku (1995), 49(Suppl 1): 37-39, 2004.
24. Yamada Y, Itano N, Narimatsu H, Kudo T, Hirohashi S, Ochiai A, Tohnai I, Ueda M and Kimata K: CD44 variant exon 6 expressions in colon cancer assessed by quantitative analysis using real time reverse transcriptase-polymerase chain reaction. Oncol Rep 10(6): 1919-1924, 2003.
25. Abbasi AM, Chester KA, Talbot IC, Macpherson AS, Boxer G, Forbes A, Malcolm AD and Begent RH: CD44 is associated with proliferation in normal and neoplastic human colorectal epithelial cells. Eur J Cancer 29A(14): 1995-2002, 1993.
26. Carr NJ, Emory TS and Sobin LH: Epithelial neoplasms of the appendix and colorectum: an analysis of cell proliferation, apoptosis, and expression of p53, CD44, bcl-2. Arch Pathol Lab Med 126(7): 837-841, 2002.
27. Khoursheed M, Mathew TC, Makar RR, Sonia L, Abul H, Asfar S, Al-Sayer H, Dashti HM and Al-Bader A: Expression of CD44s in human colorectal cancer. Pathology Oncol Res POR 8(3): 170-174, 2002.
28. Wong LS, Cantrill JE, Morris AG and Fraser IA: Expression of CD44 splice variants in colorectal cancer. Br J Surg 84(3): 363-367, 1997.
29. Lakshman M, Subramaniam V, Rubenthiran U and Jothy S: CD44 promotes resistance to apoptosis in human colon cancer cells. Exp Mol Pathol 77(1): 18-25, 2004.
30. Stoll C, Baretton G, Soost F, Terpe HJ, Domide P and Lohrs U: Prognostic importance of the expression of CD44 splice variants in oral squamous cell carcinomas. Oral Oncol 35(5): 484-489, 1999.
31. Choi SH, Takahashi K, Eto H, Yoon SS and Tanabe KK: CD44s expression in human colon carcinomas influences growth of liver metastases. Int J Cancer 85(4): 523-526, 2000.
32. Wong K, Rubenthiran U and Jothy S: Motility of colon cancer cells: modulation by CD44 isoform expression. Exp Mol Pathol 75(2): 124-130, 2003.
33. Bendardaf R, Algars A, Elzagheid A, Korkeila E, Ristamaki R, Lamlum H, Collan Y, Syrjanen K and Pyrhonen S: Comparison of CD44 expression in primary tumours and metastases of colorectal cancer. Oncol Rep 16(4): 741-746, 2006.
34. Park YS, Huh JW, Lee JH and Kim HR: shRNA against CD44 inhibits cell proliferation, invasion and migration, and promotes apoptosis of colon carcinoma cells. Oncol Rep 27(2): 339-346, 2012.
35. Du L, Wang H, He L, Zhang J, Ni B, Wang X, Jin H, Cahuzac N, Mehrpour M and Lu Y: CD44 is of functional importance for colorectal cancer stem cells. Clin Cancer Res 14(21): 6751-6760, 2008.
36. Ichikawa W: Positive relationship between expression of CD44 and hepatic metastases in colorectal cancer. Pathobiology 62(4): 172-179, 1994.
37. Galizia G, Gemei M, Del Vecchio L, Zamboli A, Di Noto R, Mirabelli P, Salvatore F, Castellano P, Orditura M and De Vita F: Combined CD133/CD44 expression as a prognostic indicator of disease-free survival in patients with colorectal cancer. Arch Surg 147(1): 18-24, 2012.
38. Visca P, Del Nonno F, Botti C, Marandino F, Sebastiani V, Di Tondo U, Donnorso RP, Trombetta G, Filippi S and Alo PL: Role and prognostic significance of CD44s expression in colorectal cancer. Anticancer Res 22(5): 2671-2675, 2002.
39. Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E and Kosma VM: Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis. Scand J Gastroenterol 33(3): 301-309, 1998.
40. Fernandez JC, Vizoso FJ, Corte MD, Gava RR, Corte MG, Suarez JP, Garcia-Muniz JL and Garcia-Moran M: CD44s expression in resectable colorectal carcinomas and surrounding mucosa. Cancer Invest 22(6): 878-885, 2004.